LifePro Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$848K Buy
+29,291
New +$854K 0.52% 56
2023
Q2
Sell
-13,052
Closed -$669K 127
2023
Q1
$669K Hold
13,052
0.49% 46
2022
Q4
$669K Sell
13,052
-847
-6% -$40.6K 0.49% 45
2022
Q3
$608K Sell
13,899
-368
-3% -$17.9K 0.35% 32
2022
Q2
$748K Buy
14,267
+2,662
+23% +$136K 0.39% 49
2022
Q1
$601K Buy
11,605
+1,673
+17% +$86.8K 0.22% 66
2021
Q4
$586K Buy
+9,932
New +$492K 0.17% 60

Other funds holding PFE

LifePro Asset Management's PFE Position: Q3 2024 in Review

LifePro Asset Management opened a new position in Pfizer (PFE) in Q3 2024: 29,291 shares worth $848K. The stake represents 0.52% of the portfolio and ranks #56 among its holdings. This is a return to the name: LifePro Asset Management previously reported a position in PFE as recently as Q1 2023.

LifePro Asset Management first reported a position in PFE in Q4 2021 and has held it in 7 quarters since. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

  • LifePro Asset Management held 29,291 shares of Pfizer worth $848K as of Q3 2024.
  • Pfizer was a new LifePro Asset Management position in Q3 2024.
  • Pfizer made up 0.52% of LifePro Asset Management's portfolio in Q3 2024, its #56 holding.
  • LifePro Asset Management first reported a position in Pfizer in Q4 2021 and has held it in 7 quarters since.
  • 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on LifePro Asset Management's 13F filing for Q3 2024, filed 9 Oct 2024.